Black Diamond Therapeutics develops cancer drugs that target families of related gene mutations in patients with tumors. It last closed at $1.31 on Nov 20, down 5.76% on the day. The next earnings report for BDTX is expected around Mon, Mar 15, 2027, after the close. For the quarter ended Sep 2026, BDTX reported EPS of -$0.17 on revenue of $0. Over its last 8 reports the stock moved an average of 7.0% the session after earnings.
AI Auto Pilots
Is BDTX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold BDTX.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on BDTXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
BDTX · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold
The stock is 26% below its 20 day and 37% below its 50 day average. It is 62% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 33), near oversold. The nearest support is the Pivot S1 at $1.28, and the nearest resistance the Pivot at $1.34.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 10.2%/day
Key levels
$4.0552 week high+209.2%
$2.12200 day average+61.8%
$1.90Swing high (Jul 22)+45.0%
$1.88100 day average+43.5%
$1.7950 day average+36.6%
$1.6520 day average+26.0%
$1.38Pivot R1+5.3%
$1.34Pivot+2.3%
$1.3152 week low+0.0%
$1.31Last close
$1.28Pivot S1−2.3%
Indicators
RSI (14)
33.00
Weak, oversold below 30
Neutral
MACD
-0.13
Below its signal line
Bearish
Stochastic
4.5
Near the bottom of its range
Oversold
ADX (14)
21.9
Weak trend
Williams %R
-100.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-140.8
Oversold below −100, overbought above 100
Oversold
Rate of change
−24.5%
Change over 10 sessions
Bearish
ATR (14)
$0.13
Typical daily range, 10.2% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityNormal, 23.2%/day
Key levels
$4.0552 week high+209.2%
$2.12200 day average+61.8%
$1.90Swing high (Jul 22)+45.0%
$1.88100 day average+43.5%
$1.7950 day average+36.6%
$1.6520 day average+26.0%
$1.38Pivot R1+5.3%
$1.34Pivot+2.3%
$1.3152 week low+0.0%
$1.31Last close
$1.28Pivot S1−2.3%
Indicators
RSI (14)
32.24
Weak, oversold below 30
Neutral
MACD
-0.19
Below its signal line
Bearish
Stochastic
7.0
Near the bottom of its range
Oversold
ADX (14)
11.9
No clear trend
Williams %R
-100.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-232.7
Oversold below −100, overbought above 100
Oversold
Rate of change
−33.8%
Change over 10 sessions
Bearish
ATR (14)
$0.30
Typical daily range, 23.2% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for BDTX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how BDTX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow BDTX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for BDTXHow many large options trades hit BDTX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in BDTX in the last 90 days.
From SEC Form 4 filings by BDTX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BDTX is in one of them and how their past BDTX trades turned out.
Black Diamond Therapeutics is a drug developer based in Cambridge, Massachusetts. It develops cancer medicines designed to block families of related gene mutations rather than a single mutation, aiming to treat patients whose tumors have limited treatment options. Its lead candidate, silevertinib, is being tested in patients with lung cancer and brain tumors. The company has also licensed another candidate to Servier, which is developing it for cancer and genetic diseases.